Pavel Strop, Ph.D.

Vice President of Biologics Discovery

Dr. Strop has over 20 years of experience in multiple therapeutic areas focusing on improving disease understanding at the molecular level and applying this knowledge to design novel therapeutics and technologies. He authored more than 65 publications and is an inventor on 19 patents. Previously, as Executive Director, BMS, Dr. Strop established protein engineering group and lead Redwood city Discovery Biotherapeutics group consisting of teams with broad areas of expertise including protein engineering, antibody generation, recombinant proteins, automation & HTS, transgenic discovery, and protein analytics. His team formed close partnerships with biology leaders to jointly design, execute, and advance projects focusing on next generation immuno-oncology and tumor microenvironment therapies. Prior to BMS, Dr. Strop was a Director of Biochemistry at Rinat/Pfizer where he developed and applied novel technologies for oncology including site-specific antibody drug conjugates and bispecifics. Dr. Strop received his Ph.D. from Caltech where he elucidated structural mechanism of mechanosensitive ion channels and completed his postdoc training at Stanford where he studied proteins involved in synaptic neurotransmission.